Citadel Advisors’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,459
Closed -$149K 14172
2025
Q4
$133K Buy
+33,459
New +$124K ﹤0.01% 11418
2025
Q1
Sell
-197,205
Closed -$1.36M 15513
2024
Q4
$1.36M Buy
197,205
+120,909
+158% +$886K ﹤0.01% 6410
2024
Q3
$443K Buy
76,296
+56,723
+290% +$344K ﹤0.01% 8518
2024
Q2
$104K Sell
19,573
-24,879
-56% -$114K ﹤0.01% 10853
2024
Q1
$169K Buy
+44,452
New +$161K ﹤0.01% 10587
2023
Q2
Sell
-4,123
Closed -$21.5K 15194
2023
Q1
$21.5K Sell
4,123
-54,994
-93% -$395K ﹤0.01% 13018
2022
Q4
$439K Buy
+59,117
New +$533K ﹤0.01% 8520
2022
Q3
Sell
-129,715
Closed -$1.55M 13563
2022
Q2
$996K Buy
129,715
+103,436
+394% +$868K ﹤0.01% 7022
2022
Q1
$266K Buy
26,279
+7,969
+44% +$72.8K ﹤0.01% 10868
2021
Q4
$132K Buy
+18,310
New +$100K ﹤0.01% 12429
2021
Q3
Sell
-34,637
Closed -$133K 14607
2021
Q2
$133K Sell
34,637
-3,634
-9% -$13.6K ﹤0.01% 12640
2021
Q1
$147K Buy
+38,271
New +$157K ﹤0.01% 12064

Other funds holding SRTS

Citadel Advisors's SRTS Position: Q1 2026 in Review

Citadel Advisors sold out of Sensus Healthcare (SRTS) in Q1 2026, closing a stake of 33,459 shares — an estimated $149K sold.

Citadel Advisors first reported a position in SRTS in Q1 2021 and held it in 12 quarters. The position peaked at $1.36M in Q4 2024. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Citadel Advisors reported no remaining Sensus Healthcare position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 33,459 Sensus Healthcare shares in Q1 2026, an estimated $149K.
  • Citadel Advisors first reported a position in Sensus Healthcare in Q1 2021 and held it in 12 quarters.
  • Citadel Advisors's Sensus Healthcare position peaked at $1.36M in Q4 2024.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.